SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Investors are actively debating the sustainability of the semiconductor rally as SOXL experiences heightened volatility, with community sentiment split between those viewing recent pullbacks as prime accumulation opportunities and others concerned about significant leverage decay and potential market correction. The conversation is largely centered on gauging new support levels amid shifting geopolitical narratives and the highly anticipated upcoming IPO of SpaceX, which traders are closely watching for its broader impact on market liquidity.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently driving massive market excitement following its historic IPO, with investors focused on the stock's significant valuation and its potential to benefit from forced buying by index funds. Community discussion is split between bullish sentiment fueled by Elon Musk's long-term vision for aerospace dominance and skeptical warnings about the company's lack of current profitability.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors weigh strong AI-driven memory demand against technical resistance near the $1,000 level. The community is heavily focused on potential catalysts including upcoming earnings and rumors surrounding a geopolitical peace deal, with many bulls remaining confident in the stock's long-term rerating despite volatility and short-term consolidation.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors debate the impact of a recent capital raise against the backdrop of breakthrough Phase 3 trial data for its hereditary angioedema therapy. Community sentiment is deeply divided between long-term bulls highlighting the potential for a commercialized gene-editing cure and skeptical traders concerned about dilution and ongoing short interest.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors aggressively debate the sustainability of the current market rally, with many traders leveraging inverse ETFs to bet against perceived overvaluation in AI and semiconductor stocks. The community is actively divided between those bracing for a potential correction driven by geopolitical instability and those dismissing bearish sentiment as premature gambling.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending due to its relentless parabolic rally, with community sentiment split between those capitalizing on the massive momentum driven by AI storage demand and those bracing for an inevitable, brutal correction. Investors are intensely debating the sustainability of this once-in-a-generation price surge, with discussions dominated by comparisons to historical market bubbles and the impact of extreme short squeezes.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is facing intense debate as investors weigh its role as an AI and government infrastructure leader against broader software sector weakness. Community sentiment remains polarized, with vocal bulls focusing on long-term government contract potential and margin expansion, while skeptics are highlighting technical price breakdowns and concerns over market valuation relative to other high-profile tech plays.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is facing significant volatility and investor frustration as market participants debate its valuation relative to the upcoming SpaceX IPO, with many questioning the fund's lack of transparency regarding management actions and recent dilution. While some investors see the current pullback as a bargain opportunity to gain exposure to a basket of high-growth tech firms including Anthropic and OpenAI, others are concerned that the fund's premium is evaporating now that direct access to its largest holdings is becoming possible.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased volatility and community discussion as investors weigh the upcoming Goliath mainnet launch against concerns over historical price patterns. While proponents highlight the potential for infrastructure-grade adoption, skeptics remain vocal about the project's transparency and tendency to experience sharp pullbacks following speculative spikes.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is experiencing heightened market volatility as traders react to shifting regulatory timelines for the Clarity Act and broader institutional rotation within the crypto-infrastructure sector. Investors are actively debating the stock's long-term valuation in light of insider selling activity, competitive pressures from major payment networks, and the potential impact of future interest rate policies on stablecoin revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ovid Therapeutics (OVID) to Release Earnings on Tuesday

Ovid Therapeutics (NASDAQ:OVID) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

Ovid Therapeutics (NASDAQ:OVID) Sees Large Decline in Short Interest

Ovid Therapeutics (NASDAQ:OVID - Get Free Report) saw a significant decline in short interest during the month of April. As of April 15th, there was short interest totaling 6,957,013 shares, a decline of 25.5% from the March 31st total of 9,337,824 shares. Based on an average trading volume of...

Ovid Therapeutics (NASDAQ:OVID) Given Average Recommendation of "Buy" by Analysts

Shares of Ovid Therapeutics (NASDAQ:OVID - Get Free Report) have been assigned an average rating of "Buy" from the ten research firms that are covering the firm, MarketBeat.com reports. One research...

Ovid Therapeutics' (OVID) "Outperform" Rating Reiterated at Wedbush

Wedbush reiterated an "outperform" rating and issued a $7.00 price target on shares of Ovid Therapeutics in a report on Wednesday...

Short Interest in Ovid Therapeutics (NASDAQ:OVID) Increases By 71.2%

Ovid Therapeutics (NASDAQ:OVID - Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 9,337,824 shares, an increase...

HC Wainwright Issues Positive Forecast for OVID Earnings

Ovid Therapeutics (NASDAQ:OVID - Free Report) - Equities research analysts at HC Wainwright boosted their Q2 2026 earnings per share (EPS) estimates for Ovid Therapeutics in a research note issued on...

Ovid Therapeutics (NASDAQ:OVID) Price Target Raised to $4.00

HC Wainwright boosted their price objective on shares of Ovid Therapeutics from $2.00 to $4.00 and gave the company a "buy" rating in a research report on Thursday...

Ovid Therapeutics' (OVID) Buy Rating Reaffirmed at BTIG Research

BTIG Research reiterated a "buy" rating and issued a $4.00 price objective on shares of Ovid Therapeutics in a report on Thursday...

Lifesci Capital Has Negative Estimate for OVID Q1 Earnings

Ovid Therapeutics (NASDAQ:OVID - Free Report) - Analysts at Lifesci Capital dropped their Q1 2026 earnings per share estimates for Ovid Therapeutics in a research note issued to investors on Tuesday...

Ovid Therapeutics (NASDAQ:OVID) Receives Consensus Recommendation of "Buy" from Brokerages

Shares of Ovid Therapeutics (NASDAQ:OVID - Get Free Report) have received an average rating of "Buy" from the nine research firms that are currently covering the company, Marketbeat Ratings reports...

Ovid Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering better, gentler medicines for the brain. It discovers and develops differentiated, small molecule medicines for neurological and neuropsychiatric disorders with significant unmet need. The company was founded by Matthew During and Jeremy M. Levin on April 1, 2014 and is headquartered in New York, NY.

OVIDOvid Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OVID News